Impacts of a federal shutdown are hitting Guam, with members of Congress unable to reach a compromise on a budget for the U.S. government’s budget by the Oct. 1 start of fiscal year 2026. While ...
Sanofi says that its experimental drug amlitelimab has the potential to become a ‘best-in-class’ maintenance therapy for atopic dermatitis (AD) after reporting new phase 2b data. The latest results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback